Targeted Therapy of Breast and Gynecological Cancers with Cytotoxic Analogues of Peptide Hormones
- 18 August 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 4 (5) , 652-658
- https://doi.org/10.1021/mp0700514
Abstract
Gynecological cancers such as breast, ovarian, and endometrial carcinoma express receptors for luteinizing hormone-releasing hormone (LHRH), bombesin/gastrin-releasing peptide (BN/GRP), and somatostatin (SST). These tumors are therefore suitable candidates for targeted therapy with cytotoxic hybrid molecules consisting of a cytotoxic radical and a peptide hormone analogue as a carrier. These compounds have been shown to be more active and less toxic in vivo than nontargeted chemotherapy in models of various human cancers which express the respective receptors. The current review summarizes experimental and clinical findings with cytotoxic peptide hormone analogues of LHRH (AN-152 [AEZS 108], AN-207), BN/GRP (AN-215), and SST (AN-238) in breast, ovarian, and endometrial cancers.Keywords
This publication has 39 references indexed in Scilit:
- Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinationsProceedings of the National Academy of Sciences, 2006
- Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215: Low induction of multidrug resistance proteinsEuropean Journal Of Cancer, 2005
- Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone–releasing hormone analogues AN-152 and AN-207Fertility and Sterility, 2005
- Expression of gastrin-releasing peptide receptors in endometrial cancerJournal of the American College of Surgeons, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancersThe Prostate, 2000
- Gastrin-Releasing Peptide Receptors in Non-Neoplastic and Neoplastic Human BreastThe American Journal of Pathology, 1999
- Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238International Journal of Cancer, 1999
- Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerJournal of Clinical Laboratory Analysis, 1989
- Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patientsGynecologic Oncology, 1984